This is the biggest drug in our country. That's why this is the most important of all the MFN announcements we've made. This is going to have the biggest impact on the American people. All Americans, even those who are not on Medicaid and Medicare, are going to be able to get the same price for their drugs, for their GLP drugs. This happened because of the vision of David Ricks, of Mike Dusar and the other people and the people on our team who figured out a way to align the interests of the shareholders of their company with the health of the American public. (35:39–35:49)
CLAIM
Asserts that all Americans will have access to the same pricing for GLP drugs, regardless of Medicaid or Medicare status.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
